President
Andrew Field, Australia

Dr Field graduated from medicine at University of New South Wales in 1978, completed his FRCPA anatomical pathology training in 1985, and then pursued further training in cytopathology at the John Hopkins, Karolinska and Flinders Hospitals leading to him gaining the FIAC in 1990 and the RCPA Cytopathology Diploma in 1996. He is Deputy Director and senior consultant in the Department of Anatomical Pathology at St Vincent’s Hospital, Sydney, senior lecturer at the University of New South Wales, and Associate Professor at Notre Dame University Medical School, Sydney. He is a past president of the Australian Society of Cytology and past and recently re-elected Board member of the Papanicolaou Society of Cytology, and past member of the IAC Task Force for promoting education and professional development in cytology in developing countries and the IAC Membership and Site Selection Committees. Currently he is the Vice President of the International Academy of Cytology and co-chair of the IAC Education and QA Committee, which has reconstituted the IAC Tutorials. He is on the editorial board and reviews for Diagnostic Cytopathology, Cancer Cytopathology, ACTA Cytologica, Journal of the American Society of Cytology, Cytopathology and Cytojournal. With the support of the Papanicolaou Society and local organizers, he has organized and taught at sixteen weeklong FNB tutorials in Kampala, Lagos, Kano, Dar Es Salaam, Cape Town, Addis Ababa Nairobi and Katmandu. These tutorials commenced in 2007 and have been given with the other speakers including Dr William Geddie, from the University Hospital Network, Toronto, and Dr Matthew Zarka, from the Mayo Clinic in Scottsdale. He has been an invited lecturer at the Kuwait Postgraduate Tutorial in 2013, and an invited speaker at the IAC Tutorials and USCAP, IAP, Asian Pacific IAP and other congresses. He is committed to fostering the development of cytopathology in the developing world. His major diagnostic, teaching, publication, writing and research interests are in FNB cytopathology especially of the lymph nodes, breast, infectious diseases and thyroid, and in sur¬gical pathology of the breast, infections including AIDS, and the gastrointestinal tract. In 2011, he received the Papanicolaou Society Award for Interventional Cytopathologist of the Year.

Past-President
Robert Osamura, Japan

Dr. Robert Y. Osamura, MD, FIAC is Professor and Director of Diagnostic Pathology Center at International University of Health and Welfare and served as Chairman of the Japanese Society of Clinical Cytology(JSCC), the largest national society of cytology worldwide with over 11.000 members. Dr. Osamura graduated from Keio University School of Medicine in Tokyo, and trained in pathology at University of Colorado Medical Center, Denver, Colorado, USA and completed a Fellowship at Henry Ford Hospital, Detroit, Michigan.

His research interests focused on the application of immunohistochemical techniques to diagnostic pathology and cytology leading him lately into the field of molecular pathology & cytology. Currently, he is involved in developing roles for morphology in molecular targeted cancers therapy in the areas of breast cancers, GIST, lung cancers and colo-rectal cancers. He is particularly interested in emphasizing the significance of cytological material as source of good targets for the application of various molecular techniques.
Dr. Osamura has been serving as a member of numerous Editorial Boards in cytology and also pathology. Dr. Osamura organized the 47th Annual Meeting of JSCC in Yokohama in 2006 which attracted 4700 attendees. Since 2004 Dr. Osamura has been on the Executive Council of the IAC, serving as Vice President and as a Chair of Constitution and By-Laws Committee. The for the last three years as President and he is looking forward to continuing working hard with all of the members of IAC for "global encouragement and interaction in cytological activities" for the best in diagnosis, therapy and prevention of the diseases.

President-Elect
Secretary-Treasurer

Fernando Schmitt, Portugal

Professor Fernando Schmitt is Professor of Pathology at the University of Porto, Senior Researcher and Head of Molecular Pathology Unit at IPATIMUP, President of the Portuguese Society of Cytology and General Secretary of the International Academy of Cytology (IAC). He has authored more than 435 papers in peer-review journals, 23 book chapters and he is editor of three books, one of molecular pathology, other of cytopathology and other of breast cytopathology. Prof Schmitt is widely considered a world-leading expert in cytopathology and breast cancer. Fernando was a fellow at the Karolinska Medical Hospital, Stockholm, and was Professor of Pathology at the University of São Paulo (USP), Brazil and University of Toronto, Canada. He was also Director of the Department of Medicine at Laboratoire national de santé, Luxembourg. His research work is on breast cancer, with emphasis on molecular markers, cell adhesion and invasion, therapeutic targets and mechanisms of resistance. In the last years, his research work has been dedicated to the study of molecular markers on cytological material. Fernando serves as Associate Editor of six major scientific journals and sits on the editorial board of many others. He has also been chair, president or scientific director of several major European, Portuguese and Brazilian scientific societies of pathology and cytology. Currently he is the Secretary-General of the IAC. Fernando received the prize of Educator of the Year 2011 by the Papanicoloau Society of Cytology (USA), also received the prize GOLDBLATT AWARD 2013 from the International Academy of Cytology. 

Vice-President
Syed Z. Ali, U.S.A.
Dr. Ali serves as Professor of Pathology and Radiology at the Johns Hopkins University School of Medicine as well as the Director of the Division of Cytopathology at The Johns Hopkins Hospital. He received his Pathology residency training at North Shore University Hospital in New York with fellowships in Surgical Pathology at the Memorial Sloan-Kettering Cancer Center in New York City and Cytopathology at The Johns Hopkins Hospital in Baltimore.
Known as one of the most traveled pathologists, Dr. Ali has well over 275 invited lectures, keynote speeches and visiting professorships. In collaboration with international societies and universities, he directs or co-directs several annual major cytopathology tutorials.

Dr. Ali has published extensively with over 280 articles in major scientific journals, over 30 books, book chapters and electronic media. He is the founding editor-in-chief of the Journal of the American Society of Cytopathology (JASC) and has served as member of the executive board and chair of the scientific program committee and the educational development committee of the American Society of Cytopathology (ASC). He presently serves as the President-elect of the ASC and chair of the continuing education committee of the International Academy of Cytology (IAC). He is a fellow of both, the Royal College of Pathologists (UK) and the IAC. He is recipient of the ASC's "Warren R. Lang Award" in 1996, the "President's Award" in 2012 and "Excellence in Education Award" in 2015.

Vice-President
Ashish Chandra, United Kingdom

Dr Ashish Chandra is the lead uropathologist and cytopathologist at Guy's & St. Thomas' Hospitals, London where he has been based since 2001. He is a member of the Cytopathology specialist advisory committee at RCPath, an active member of the BAC and Deputy editor of Cytopathology.
He has an interest in FNA, ROSE and in developing reporting terminologies including the UK RCPath terminology for thyroid cytology, and a contributor to the Paris and Milan systems. He is a co-editor of the forthcoming International system for reporting serous fluid cytology.

Editor
Kari J. Syrjänen (Finland)

Dr. Syrjänen is currently the Chief Medical Director, Biohit HealthCare Oyj (Helsinki, Finland), and holds the status of Visiting Professor, Barretos Cancer Hospital, Brazil. He graduated in Medicine, University of Helsinki, in 1974, where he received his Ph.D. in pathology (1975). Board-certified pathologist (1980), and FIAC (1993). He was Professor and Chairman, Department of Pathology, University of Kuopio in 1989-1999, and Director of Cytopathology Laboratory, Finnish Cancer Society (Kuopio) for 16 years (1981-1996). Dr. Syrjänen served as President of the Finnish Society of Clinical Cytology (FSCC)(1989-1998) and organized the 19th European Congress of Cytology in Turku (1991), being President of the European Federation of Cytology Societies (EFCS)(1990-1991). Dr. Syrjänen is the founding member of the Board, International Papillomavirus Society (IPVS)(1995-2016) and EUROGIN (1992-). He is Honorary Member of the American- (ASCCP), Italian- (ISCCP) and Hungarian (HSCCP) Society of Colposcopy and Cervical Pathology. Dr. Syrjänen was the recipient of Maurice Goldblatt Cytology Award in 2010. Apart from Acta Cytologica, he is an Editorial Board member in 16 other journals and Associate Editor-in-Chief (CME Journal of Gynecologic Oncology). Dr. Syrjänen has authored/edited 9 international books, written over 50 book chapters, and published over 900 original papers and reviews in peer-reviewed journals.

Daisuke Aoki, Japan
Professor, Department of Obstetrics and Gynecology, Keio University School of Medicine

Dr. Daisuke Aoki has been a professor and the chairman of Department of Obstetrics and Gynecology at Keio University School of Medicine and Director of the Gynecology Division at Keio University Hospital in Tokyo, Japan, since 2005. He specializes in gynecologic oncology. He is a board-certified obstetrician and gynecologist of the Japan Society of Obstetrics and Gynecology (JSOG) and the board director and secretary general of the society. He is also a board-certified cytopathologist of the Japanese Society of Clinical Cytology (JSCC) and a board-certified gynecologic oncologist of Japan Society of Gynecologic Oncology (JSGO). He currently serves as President of the JSCC, Chairperson of the JSGO, Vice President of Japanese Gynecologic Oncology Group, Vice President of Asian Society of Gynecologic Oncology, Vice President of Japan Society of Clinical Genetics in Obstetrics and Gynecology, council member of Japan Society of Clinical Oncology, He also served as Congress President of the International Congress of Cytology which was held in Yokohama, Japan in 2016 (ICC2016).
Dr. Aoki has clinical and research interests in gynecologic oncology, especially in the screening and prevention of HPV-related pre-invasive diseases of the uterine cervix as well as cervical cancer, including quality control and assurance of cancer screening. He is also contributing to studies about hereditary gynecological cancers, and cancer genomics. He has authored and co-authored more than 200 peer reviewed scientific articles mainly about the field of gynecologic oncology. 

Lan Chen, China

Dr. Lan Chen graduated from West China University of Medical Sciences (1986-1992) in China and started her pathology training in Beijing Tong Ren Hospital (1992-1996). Upon finishing her residency, she went abroad to pursue higher academic education. She received her PhD in Anatomical and cellular Pathology Department, Chinese University of Hong Kong (1996-1999), and conducted post-doctoral research in Department of Pharmaceutical and Molecular Biology, School of Pharmacy, University of London (2000-2001) and Pathology Department of Hong Kong University (2003-2006). In 2007, she came back to Beijing to join the Pathology Department of Beijing Hospital, which plays a leading role in cytological diagnosis in China. She is now the only full-time cytopathologist in the department.

Her previous research focused on molecular genetic study of Alzheimer's disease (AD), Down Syndrome (DS) and oral squamous cell carcinoma and ameloblastoma with related genes on Ch21, and she has published over 10 publications in international peer-reviewed journals. Now as a diagnostic cytopathologist, her major interests include FNA of thyroid, lymphonode, EBUS TBNA and exfoliated cytology of sputum, urine and effusion. She has been applying IHC and molecular genetic techniques for accurate cytology diagnosis, including typing of lung cancers for target therapy, definitive diagnoses of uroepithelial and thyroid carcinoma.

She is actively involved in the activities of Chinese Cytology Association (CCA) as an academic lecturer, diagnostic cytology course trainer and translator for international academic exchanges. She is also the liaison person between IAC and CCA and was one of the key organizers of recent 2015 IAC Beijing Tutorial, which was a big success and attracted over 200 attendees.

She would like to further promote IAC's influence in China as well as China's presence in international activities and help her fellow colleagues to join IAC for academic improvements in the future

Pamela Michelow, South Africa

Dr Pamela Michelow graduated from the University of the Witwatersrand with an MBBCh in 1989. In 2007, she completed an MSc in Cytopathology from Stellenbosch University and in 2016, a postgraduate diploma in Health Science Education from University of the Witwatersrand. She currently has a joint post at the University of the Witwatersrand and the National Health Laboratory Service (the South African public sector laboratory).
She is past president of the South African Society for Clinical Cytology (SASCC) and participated as an expert committee member to advise the South African Department of Health on cervical screening policy from 2011-2016. She also served on the International Academy of Cytology general policy and long-term planning committee from 2001-2003 and again in 2008-2010.
Dr Michelow has published over 70 journal articles and book chapters, is an editorial board member for several cytopathology journals, has organised symposia and workshops, and is frequently invited to speak at both national and international pathology congresses. She has continuing interests in visual literacy, the roles of exfoliative and aspiration biopsy cytology in under-resourced communities and in quality standards in cytopathology. 

Ritu Nayar, USA

Ritu Nayar graduated from Maulana Azad Medical College, Delhi, India, with an MBBS and MD in Pathology, after which she moved to the United States, where she completed Pathology Residency, followed by Surgical Pathology and Cytopathology fellowships with Drs Steven Silverberg, Tom Bonfiglio and David Wilbur.

Currently Dr Nayar is Professor of Pathology, Vice Chair of Education and Faculty Development and Director of Cytopathology at Northwestern University, Chicago. She is a Trustee of the American Board of Pathology (ABP) since 2015 and Chairs the ABP Cytopathology Examination and Anatomic Pathology Continuing Certification Test Committees. Dr Nayar has served as a member of the IAC Executive Council and as the IAC representative and Co-Chair of the Cytopathology Education and Technology Consortium (CETC) since 2013.

Dr. Nayar's practice includes clinical service, administration, teaching and translational research. She has published over 175 journal articles and books/book chapters; is co-editor of the 2nd and 3rd editions of the Bethesda Atlas for Reporting Cervical Cytology Bethesda Atlases and contributor for the Bethesda System for Reporting Thyroid Cytopathology and Paris System for Reporting Urinary Cytopathology Atlases. She is an editorial board member for several pathology journals and is a frequently invited speaker, moderator and organizer for American and International Pathology Meetings.

Ritu Nayar has been an active leader and advocate in organized Pathology for over 25 years. She has chaired and served on several committees in professional organizations including the IAC, ASC, ASCP, USCAP, CAP, PSC and with the US National Cancer Institute (NCI) and the American Board of Pathology (ABP). She is Past President of the American Society of Cytopathology, and Past Chair of the International Academy of Cytology (IAC) Education Committee. Dr Nayar received the 2018 American Society of Cytopathology's highest honor, the Papanicolaou Award, given in recognition of meritorious contributions in the field of Cytopathology and was the recipient of the Inaugural Patricia Alonso Award for Contributions to Women's Health from the Mexican Academy of Cytopathology in 2016.

Esperanza Teuzaba Torres

Completed her graduation in Medicine and her residency in Pathology at the Universidad del Rosario, San Jose Hospital, Bogotá Colombia, in 1986.
She trained in Cytopathology at the Jackson Memorial Hospital, University of Miami. Miami and is currently professor at the School of Medicine and Health Sciences, Universidad del Rosario, and the University Foundation of Health Science. Bogota.
She is the scientific director of Patolab laboratory, Clínica de la Mujer, Bogotá. Vice president of the Colombian Association of Pathology and director of the Chapter of Cytopathology.
Currently working in the Cervical Cancer Agreement Group, developing guidelines, outlines and efforts to reduce the incidence and mortality of cervical cancer in Colombia.
Doing an important task in the introducing liquid based cytology to the country in 2012, as well as the validation and diffusion of anal cytology.
For the last 8 years Esperanza has worked actively in the organization of Scientific Meetings, Cytopathology Congresses and an IAC Tutorial in Bogotá, Colombia.

CYTOTECHNOLOGIST MEMBER
Shirley Greening, U.S.A.

At Thomas Jefferson University in Philadelphia, USA from 1983 - 2014, Ms. Greening was Professor and Chair of the Department of Bioscience Technologies, which conducts BS and MS programs in Biotechnology, Cytotechnology/Cell Sciences and Medical Laboratory Science.

Ms. Greening has been the Chair of the Cytotechnology Advisory Committee of the American Society of Cytopathology (ASC), and is a Past-President of the American Society for Cytotechnology (ASCT).

An active member of the IAC since 1972, she is Chair of the IAC's Cytotechnology Awards Jury, and is Registrar for the IAC examinations.

With interests in national and international education and practice issues, Ms. Greening has served on the International Advisory Board for King Saud bin Abdulaziz University of Health Sciences in Riyadh, Saudi Arabia and was a member of ASCP's International Certification Committee.

She received the Cytotechnologist of the Year Award from the ASC in 1993, the Cytotechnologist Achievement Award of the American ASCT in 1995, and the 1997 Cytotechnology Award in Clinical Cytology from the IAC.